ATE170508T1 - Bisulfit-additionsverbindungen von argininaldehyden und ihre verwendung als thrombininhibitoren und antikoagulantien - Google Patents
Bisulfit-additionsverbindungen von argininaldehyden und ihre verwendung als thrombininhibitoren und antikoagulantienInfo
- Publication number
- ATE170508T1 ATE170508T1 AT95301389T AT95301389T ATE170508T1 AT E170508 T1 ATE170508 T1 AT E170508T1 AT 95301389 T AT95301389 T AT 95301389T AT 95301389 T AT95301389 T AT 95301389T AT E170508 T1 ATE170508 T1 AT E170508T1
- Authority
- AT
- Austria
- Prior art keywords
- argininal
- dehydes
- anticoagulants
- thrombin inhibitors
- addition compounds
- Prior art date
Links
- 229940122388 Thrombin inhibitor Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003868 thrombin inhibitor Substances 0.000 title abstract 2
- QJYRUYURLPTHLR-YFKPBYRVSA-N 2-[(4s)-4-amino-5-oxopentyl]guanidine Chemical compound O=C[C@@H](N)CCCNC(N)=N QJYRUYURLPTHLR-YFKPBYRVSA-N 0.000 title 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 title 1
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127219 anticoagulant drug Drugs 0.000 title 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- -1 L-arginine aldehyde Chemical class 0.000 abstract 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 abstract 1
- 239000003130 blood coagulation factor inhibitor Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/206,579 US5436229A (en) | 1994-03-04 | 1994-03-04 | Bisulfite adducts of arginine aldehydes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170508T1 true ATE170508T1 (de) | 1998-09-15 |
Family
ID=22767010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95301389T ATE170508T1 (de) | 1994-03-04 | 1995-03-03 | Bisulfit-additionsverbindungen von argininaldehyden und ihre verwendung als thrombininhibitoren und antikoagulantien |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5436229A (de) |
| EP (1) | EP0670310B1 (de) |
| JP (1) | JPH07278095A (de) |
| AT (1) | ATE170508T1 (de) |
| CA (1) | CA2143532A1 (de) |
| DE (1) | DE69504383T2 (de) |
| DK (1) | DK0670310T3 (de) |
| ES (1) | ES2120132T3 (de) |
| SI (1) | SI0670310T1 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
| CA2143533A1 (en) * | 1994-03-04 | 1995-09-05 | Kenneth D. Kurz | Antithrombotic agents |
| US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
| US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
| US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
| US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
| US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
| US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
| US5914319A (en) * | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
| ATE377006T1 (de) * | 1995-11-28 | 2007-11-15 | Cephalon Inc | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer |
| AU7655796A (en) * | 1995-11-30 | 1997-06-19 | C & C Research Laboratories | Sulfamide derivatives |
| US5756775A (en) * | 1995-12-13 | 1998-05-26 | Eli Lilly And Company | Process to make α,α-difluoro-β-hydroxyl thiol esters |
| US6001994A (en) * | 1995-12-13 | 1999-12-14 | Eli Lilly And Company | Process for making gemcitabine hydrochloride |
| NZ500045A (en) | 1997-04-18 | 2001-02-23 | Cephalon Inc | Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| JP2001525823A (ja) | 1997-05-15 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | 抗血栓化合物 |
| SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| HUP0401312A3 (en) * | 2001-08-21 | 2010-04-28 | Ivax Drug Res Inst | Peptide arginals and pharmaceutical compositions containing such compounds |
| MX346246B (es) | 2011-07-01 | 2017-03-13 | Novozymes As | Composicion de subtilisina estabilizada. |
| MX350874B (es) | 2011-07-01 | 2017-09-19 | Novozymes As | Composicion de detergente liquido. |
| CN105189724A (zh) | 2013-03-14 | 2015-12-23 | 诺维信公司 | 含有酶和抑制剂的水溶性膜 |
| WO2014177709A1 (en) | 2013-05-03 | 2014-11-06 | Novozymes A/S | Microencapsulation of detergent enzymes |
| CN106471110A (zh) | 2014-07-03 | 2017-03-01 | 诺维信公司 | 改进的非蛋白酶类酶稳定化 |
| US10400230B2 (en) | 2014-12-19 | 2019-09-03 | Novozymes A/S | Protease variants and polynucleotides encoding same |
| EP3950939A3 (de) | 2015-07-06 | 2022-06-08 | Novozymes A/S | Lipasevarianten und polynukleotide zur codierung davon |
| US11000050B2 (en) | 2015-10-09 | 2021-05-11 | Axichem Ab | Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prophylactic use or treatment of Salmonella infection |
| WO2018202846A1 (en) | 2017-05-05 | 2018-11-08 | Novozymes A/S | Compositions comprising lipase and sulfite |
| EP3645692B1 (de) | 2017-06-30 | 2025-12-31 | Novozymes A/S | Enzymschlammzusammensetzung |
| WO2019086530A1 (en) | 2017-11-01 | 2019-05-09 | Novozymes A/S | Polypeptides and compositions comprising such polypeptides |
| EP3704240A1 (de) | 2017-11-01 | 2020-09-09 | Novozymes A/S | Polypeptide und zusammensetzungen mit solchen polypeptiden |
| US20210002588A1 (en) | 2018-03-13 | 2021-01-07 | Novozymes A/S | Microencapsulation Using Amino Sugar Oligomers |
| EP3647398B1 (de) | 2018-10-31 | 2024-05-15 | Henkel AG & Co. KGaA | Reinigungszusammensetzungen mit dispersinen v |
| EP3647397A1 (de) | 2018-10-31 | 2020-05-06 | Henkel AG & Co. KGaA | Reinigungsmittel mit dispersins iv |
| CN114008068A (zh) | 2019-07-01 | 2022-02-01 | 巴斯夫欧洲公司 | 稳定酶的肽缩醛 |
| US20220411773A1 (en) | 2019-12-20 | 2022-12-29 | Novozymes A/S | Polypeptides having proteolytic activity and use thereof |
| WO2021236475A1 (en) * | 2020-05-18 | 2021-11-25 | Asinex Corporation | Compounds that inhibit asparagine synthetase and their methods of use |
| EP4305146A1 (de) | 2021-03-12 | 2024-01-17 | Novozymes A/S | Polypeptidvarianten |
| CN120344647A (zh) | 2022-12-23 | 2025-07-18 | 诺维信公司 | 包含过氧化氢酶和淀粉酶的洗涤剂组合物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177098B (en) * | 1979-01-04 | 1981-07-28 | Gyogyszerkutato Intezet | Process for producing new peptidyl-n-carboxy-l-arginin-a |
| HU178398B (en) * | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
| HU184368B (en) * | 1981-01-13 | 1984-08-28 | Gyogyszerkutato Intezet | Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate |
| EP0124317B1 (de) * | 1983-04-27 | 1990-04-11 | Ici Americas Inc. | Prolin-Derivate |
| HU192646B (en) * | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
| DE3606480A1 (de) * | 1986-02-28 | 1987-09-03 | Behringwerke Ag | Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung |
| US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| DE3827415A1 (de) * | 1988-08-12 | 1990-02-15 | Behringwerke Ag | Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung |
| US5204323B1 (en) * | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
| ZA905737B (en) * | 1989-07-26 | 1991-05-29 | Merrell Dow Pharma | Novel peptidase inhibitors |
| US5053392A (en) * | 1989-12-01 | 1991-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors |
| IL99527A (en) * | 1990-09-28 | 1997-08-14 | Lilly Co Eli | Tripeptide antithrombotic agents |
| EP0503203A1 (de) * | 1991-03-15 | 1992-09-16 | Merrell Dow Pharmaceuticals Inc. | Neue Thrombin-Inhibitoren |
| CA2075154A1 (en) * | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
| ZA926185B (en) * | 1991-08-22 | 1993-03-01 | Merrell Dow Pharma | Novel orally-active elastase inhibitors. |
| SE9102462D0 (sv) * | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
| AU2882792A (en) * | 1991-10-23 | 1993-05-21 | Procter & Gamble Company, The | Tripeptide derivative anti-inflammatory agents |
| ZA928581B (en) * | 1991-11-12 | 1994-05-06 | Lilly Co Eli | Antithrombotic agents |
| US5250660A (en) * | 1991-11-12 | 1993-10-05 | Eli Lilly And Company | Peptide purification process |
-
1994
- 1994-03-04 US US08/206,579 patent/US5436229A/en not_active Expired - Fee Related
-
1995
- 1995-02-28 CA CA002143532A patent/CA2143532A1/en not_active Abandoned
- 1995-03-03 DK DK95301389T patent/DK0670310T3/da active
- 1995-03-03 AT AT95301389T patent/ATE170508T1/de not_active IP Right Cessation
- 1995-03-03 SI SI9530171T patent/SI0670310T1/xx unknown
- 1995-03-03 ES ES95301389T patent/ES2120132T3/es not_active Expired - Lifetime
- 1995-03-03 DE DE69504383T patent/DE69504383T2/de not_active Expired - Fee Related
- 1995-03-03 EP EP95301389A patent/EP0670310B1/de not_active Expired - Lifetime
- 1995-03-03 JP JP7043919A patent/JPH07278095A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2143532A1 (en) | 1995-09-05 |
| DE69504383T2 (de) | 1999-02-11 |
| SI0670310T1 (en) | 1999-02-28 |
| EP0670310B1 (de) | 1998-09-02 |
| US5436229A (en) | 1995-07-25 |
| JPH07278095A (ja) | 1995-10-24 |
| ES2120132T3 (es) | 1998-10-16 |
| DK0670310T3 (da) | 1999-02-08 |
| EP0670310A1 (de) | 1995-09-06 |
| DE69504383D1 (de) | 1998-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE170508T1 (de) | Bisulfit-additionsverbindungen von argininaldehyden und ihre verwendung als thrombininhibitoren und antikoagulantien | |
| PT672658E (pt) | Agentes antitromboticos | |
| DK0672659T3 (da) | Antitrombotiske midler | |
| BR9806752A (pt) | Ftalazinonas. | |
| ATE290529T1 (de) | Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor | |
| EA200300293A1 (ru) | Противовоспалительные конденсированные пирролокарбазолы | |
| EA199700186A1 (ru) | Новые дипептидные амидины, используемые в качестве ингибиторов тромбина | |
| DE69716823D1 (de) | Thrombin-Inhibitoren als anticoagulierende Mittel | |
| BG104899A (en) | Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis | |
| PL354030A1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| ATE425139T1 (de) | Benzamidinderivate | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| EA200200625A1 (ru) | Антипикорнавирусные соединения и композиции, их фармацевтическое применение и вещества для их синтеза | |
| ATE403712T1 (de) | Verwendung von polymerisaten, enthaltend thermoplastische polymere als filterhilfs- und/oder stabilisierungsmittel | |
| ATE194851T1 (de) | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien | |
| ATE148109T1 (de) | Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids | |
| ATE302026T1 (de) | Zusammensetzung enthaltend einen inhibitor der signaltransduktion von heterometrischen g proteinen in kombination mit einem antihypertensiven mittel zu einer therapeutischen verwendung in der behandlung von arterieller hypertonie | |
| EA200100151A1 (ru) | Производные пиперазинона и их применение | |
| ES2170380T3 (es) | Nuevos insecticidas y acaricidas de hidrazinacarboxilato. | |
| EA200200321A1 (ru) | Апоптин-ассоциированный белок | |
| WO2001096297A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| ID27964A (id) | Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
| DE60203726D1 (de) | Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden | |
| EA199900257A1 (ru) | Промежуточные соединения для получения ингибиторов вич-протеазы и способы получения ингибиторов вич-протеазы | |
| ATE285230T1 (de) | Verwendung von chrysanthon-naturstoffen, die eine antiangiogene wirkung haben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |